Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
1993 Aug 15;9016:7508-12.
Show Gene links
Show Anatomy links
Amyloid beta-protein activates tachykinin receptors and inositol trisphosphate accumulation by synergy with glutamate.
Kimura H
,
Schubert D
.
???displayArticle.abstract???
The biological function of the soluble form of the amyloid beta-protein (ABP) was examined by assaying its interaction with neuronal receptors expressed in Xenopus oocytes. ABP weakly activated tachykinin receptors, but in the presence of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methylisoxazole-4- propionate-type glutamate receptors ABP-induced responses were greatly enhanced. Glutamate and ABP together also induced accumulation of inositol trisphosphate and increases in intracellular Ca2+. These observations suggest that in the presence of glutamate, ABP can activate tachykinin receptors and phosphatidylinositol turnover. ABP may therefore act as a neuromodulatory peptide.
Cai,
Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.
1993, Pubmed
Cai,
Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.
1993,
Pubmed
Chartier-Harlin,
Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene.
1991,
Pubmed
Erondu,
Regional distribution of type II Ca2+/calmodulin-dependent protein kinase in rat brain.
1985,
Pubmed
Esch,
Cleavage of amyloid beta peptide during constitutive processing of its precursor.
1990,
Pubmed
Folkers,
Biological evaluation of substance P antagonists.
1984,
Pubmed
Goate,
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.
1991,
Pubmed
Haass,
Amyloid beta-peptide is produced by cultured cells during normal metabolism.
1992,
Pubmed
Hollmann,
Cloning by functional expression of a member of the glutamate receptor family.
1989,
Pubmed
,
Xenbase
Hollmann,
Ca2+ permeability of KA-AMPA--gated glutamate receptor channels depends on subunit composition.
1991,
Pubmed
,
Xenbase
Joseph,
Amyloid beta-protein fragment 25-35 causes activation of cytoplasmic calcium in neurons.
1992,
Pubmed
Koh,
Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage.
1990,
Pubmed
Kusano,
Cholinergic and catecholaminergic receptors in the Xenopus oocyte membrane.
1982,
Pubmed
,
Xenbase
Lechleiter,
Subcellular patterns of calcium release determined by G protein-specific residues of muscarinic receptors.
1991,
Pubmed
,
Xenbase
Malenka,
An essential role for postsynaptic calmodulin and protein kinase activity in long-term potentiation.
1989,
Pubmed
Malinow,
Inhibition of postsynaptic PKC or CaMKII blocks induction but not expression of LTP.
1989,
Pubmed
Masters,
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
1985,
Pubmed
Masu,
cDNA cloning of bovine substance-K receptor through oocyte expression system.
,
Pubmed
,
Xenbase
Mattson,
beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity.
1992,
Pubmed
Miledi,
Latencies of membrane currents evoked in Xenopus oocytes by receptor activation, inositol trisphosphate and calcium.
1989,
Pubmed
,
Xenbase
Miller,
Regulation of brain type II Ca2+/calmodulin-dependent protein kinase by autophosphorylation: a Ca2+-triggered molecular switch.
1986,
Pubmed
Moriyoshi,
Molecular cloning and characterization of the rat NMDA receptor.
1991,
Pubmed
,
Xenbase
Murrell,
A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease.
1991,
Pubmed
Parker,
Neurotensin and substance P receptors expressed in Xenopus oocytes by messenger RNA from rat brain.
1986,
Pubmed
,
Xenbase
Rogers,
The characterization and localization of the glutamate receptor subunit GluR1 in the rat brain.
1991,
Pubmed
Saito,
Distribution of protein kinase C-like immunoreactive neurons in rat brain.
1988,
Pubmed
Seubert,
Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.
1992,
Pubmed
Seubert,
Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide.
1993,
Pubmed
Shigemoto,
Cloning and expression of a rat neuromedin K receptor cDNA.
1990,
Pubmed
,
Xenbase
Shoji,
Production of the Alzheimer amyloid beta protein by normal proteolytic processing.
1992,
Pubmed
Silva,
Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice.
1992,
Pubmed
Tanaka,
Structure and functional expression of the cloned rat neurotensin receptor.
1990,
Pubmed
,
Xenbase
Tsuchida,
Tissue distribution and quantitation of the mRNAs for three rat tachykinin receptors.
1990,
Pubmed
Yankner,
Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.
1990,
Pubmed
Yokota,
Molecular characterization of a functional cDNA for rat substance P receptor.
1989,
Pubmed
,
Xenbase
Yokota,
Delineation of structural domains involved in the subtype specificity of tachykinin receptors through chimeric formation of substance P/substance K receptors.
1992,
Pubmed
